CELL

Israel`s Gamida Cell raises $40 million for bone marrow trial

Israel`s Gamida Cell raises $40 million for bone marrow trial

Published 19/06/2017

Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.

[more…]

BrainStorm seeks early approval for stem cell treatment in Canada

BrainStorm seeks early approval for stem cell treatment in Canada

Published 21/02/2017

Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes late-stage clinical trials.

[more…]

Cellectis gets U.S. go-ahead to test `off-the-shelf` cell therapy

Cellectis gets U.S. go-ahead to test `off-the-shelf` cell therapy

Published 06/02/2017

Cellectis has won U.S. regulatory approval to run an early clinical trial using its gene edited cell therapy product UCART123 for blood cancers, boosting the French biotech firm's ambitions in the hot area of cancer research.

[more…]

Stripped-down synthetic organism sheds light on nature of life

Stripped-down synthetic organism sheds light on nature of life

Published 24/03/2016

WASHINGTON Scientists on Thursday announced the creation of a synthetic organism stripped down to the bare essentials with the fewest genes needed to survive and [more…]